Search research articles
Contact Us
Filters
Showing results (51-60 of 63) with videos related to
Page
of 7
Sort By:
Journal of Medicinal Chemistry
|
May 1, 2009
Synthesis and biological characterization of B-ring amino analogues of potent benzothiadiazine hepatitis C virus polymerase inhibitors
John T Randolph, Charles A Flentge, Peggy P Huang, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 3, 2012
Thienopyridine ureas as dual inhibitors of the VEGF and Aurora kinase families
Michael L Curtin, Robin R Frey, H Robin Heyman, et al.
Journal of Medicinal Chemistry
|
June 10, 2005
Structure-based characterization and optimization of novel hydrophobic binding interactions in a series of pyrrolidine influenza neuraminidase inhibitors
Clarence J Maring, Vincent S Stoll, Chen Zhao, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 14, 2013
Aryl uracil inhibitors of hepatitis C virus NS5B polymerase: synthesis and characterization of analogs with a fused 5,6-bicyclic ring motif
A Chris Krueger, John T Randolph, David A DeGoey, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 30, 2010
Imidazo[2,1-b]thiazoles: multitargeted inhibitors of both the insulin-like growth factor receptor and members of the epidermal growth factor family of receptor tyrosine kinases
Steve D Fidanze, Scott A Erickson, Gary T Wang, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 26, 2006
Thienopyridine urea inhibitors of KDR kinase
H Robin Heyman, Robin R Frey, Peter F Bousquet, et al.
Journal of Medicinal Chemistry
|
February 4, 2005
Novel transient receptor potential vanilloid 1 receptor antagonists for the treatment of pain: structure-activity relationships for ureas with quinoline, isoquinoline, quinazoline, phthalazine, quinoxaline, and cinnoline moieties
Arthur Gomtsyan, Erol K Bayburt, Robert G Schmidt, et al.
Journal of Medicinal Chemistry
|
January 18, 2018
Synthesis and Biological Characterization of Aryl Uracil Inhibitors of Hepatitis C Virus NS5B Polymerase: Discovery of ABT-072, a trans-Stilbene Analog with Good Oral Bioavailability
John T Randolph, A Chris Krueger, Pamela L Donner, et al.
Journal of Medicinal Chemistry
|
October 27, 2006
Discovery of ((4R,5S)-5-amino-4-(2,4,5- trifluorophenyl)cyclohex-1-enyl)-(3- (trifluoromethyl)-5,6-dihydro- [1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanone (ABT-341), a highly potent, selective, orally efficacious, and safe dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
Zhonghua Pei, Xiaofeng Li, Thomas W von Geldern, et al.
Journal of Medicinal Chemistry
|
September 16, 2005
Thienopyrimidine ureas as novel and potent multitargeted receptor tyrosine kinase inhibitors
Yujia Dai, Yan Guo, Robin R Frey, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 63) with videos related to
Sort By:
Page
of 7
Journal of Medicinal Chemistry
|
May 1, 2009
Synthesis and biological characterization of B-ring amino analogues of potent benzothiadiazine hepatitis C virus polymerase inhibitors
John T Randolph, Charles A Flentge, Peggy P Huang, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 3, 2012
Thienopyridine ureas as dual inhibitors of the VEGF and Aurora kinase families
Michael L Curtin, Robin R Frey, H Robin Heyman, et al.
Journal of Medicinal Chemistry
|
June 10, 2005
Structure-based characterization and optimization of novel hydrophobic binding interactions in a series of pyrrolidine influenza neuraminidase inhibitors
Clarence J Maring, Vincent S Stoll, Chen Zhao, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 14, 2013
Aryl uracil inhibitors of hepatitis C virus NS5B polymerase: synthesis and characterization of analogs with a fused 5,6-bicyclic ring motif
A Chris Krueger, John T Randolph, David A DeGoey, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 30, 2010
Imidazo[2,1-b]thiazoles: multitargeted inhibitors of both the insulin-like growth factor receptor and members of the epidermal growth factor family of receptor tyrosine kinases
Steve D Fidanze, Scott A Erickson, Gary T Wang, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 26, 2006
Thienopyridine urea inhibitors of KDR kinase
H Robin Heyman, Robin R Frey, Peter F Bousquet, et al.
Journal of Medicinal Chemistry
|
February 4, 2005
Novel transient receptor potential vanilloid 1 receptor antagonists for the treatment of pain: structure-activity relationships for ureas with quinoline, isoquinoline, quinazoline, phthalazine, quinoxaline, and cinnoline moieties
Arthur Gomtsyan, Erol K Bayburt, Robert G Schmidt, et al.
Journal of Medicinal Chemistry
|
January 18, 2018
Synthesis and Biological Characterization of Aryl Uracil Inhibitors of Hepatitis C Virus NS5B Polymerase: Discovery of ABT-072, a trans-Stilbene Analog with Good Oral Bioavailability
John T Randolph, A Chris Krueger, Pamela L Donner, et al.
Journal of Medicinal Chemistry
|
October 27, 2006
Discovery of ((4R,5S)-5-amino-4-(2,4,5- trifluorophenyl)cyclohex-1-enyl)-(3- (trifluoromethyl)-5,6-dihydro- [1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanone (ABT-341), a highly potent, selective, orally efficacious, and safe dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
Zhonghua Pei, Xiaofeng Li, Thomas W von Geldern, et al.
Journal of Medicinal Chemistry
|
September 16, 2005
Thienopyrimidine ureas as novel and potent multitargeted receptor tyrosine kinase inhibitors
Yujia Dai, Yan Guo, Robin R Frey, et al.
Page
of 7